Statins appear to lower risk of amputation and death in veterans with peripheral artery disease (PAD), according to a recent study.
Although most patients in the United States die of another condition, cancer is the focus of most end-of-life care studies.
WASHINGTON—The VA treats about a million veterans for diabetes, nearly one-fourth of its patient population.
All Fail to Consistently Meet Performance Measures By Brenda L. Mooney HOUSTON — Cardiac patients and even some medical staff might assume they will receive the best ongoing care when they see a physician, not an advanced practice provider such… Read More
New Guidelines Significantly Different from AHA/ACC Document
By Annette M. Boyle SAN FRANCISCO — For selected patients with carotid stenosis, national guidelines recommend revascularization for primary or secondary prevention of stroke. Increasingly, though, it appears that veterans who could benefit the most from these procedures do not… Read More
Effort Seeks to Standardize Care Across VAMCs By Annette M. Boyle INDIANAPOLIS — Since the publication of the VHA directive on treatment of acute ischemic stroke (AIS) in November 2011, VA medical facilities nationwide have responded by adding structure to… Read More
Chronic Conditions Also Associated With Past Combat Experience Annette M. Boyle MINNEAPOLIS — Serious health conditions linked to post-traumatic stress disorder (PTSD) continue to mount. Researchers recently uncovered a significant link between the condition and the risk of developing heart… Read More
Annette M. Boyle ASHEVILLE, NC — Screening, frequent appointments and other interventions enabled the VA by 2010 to bring blood pressure under control in more than three-quarters of patients with hypertension. Helping the remaining one-quarter adhere to medication regimens to… Read More
HOUSTON — Heart disease is the No. 1 killer of women veterans, yet they remain undertreated
SEATTLE – While combat has long been known to increase the risk of musculoskeletal injuries, post-traumatic stress disorder (PTSD)
By Stephen Spotswood WASHINGTON – Chronic obstructive pulmonary disease (COPD) is sometimes referred to as the “quiet” or “silent” killer by clinicians trying to treat it. It presents few symptoms in its earliest stages and so is often not diagnosed… Read More
New Formulations Might Be More Effective By Annette M. Boyle BETHESDA, MD – In the last 50 years, the use of anticoagulants has transformed mortality rates for deep vein thrombosis (DVT), pulmonary embolism (PE) and atrial fibrillation, and new anticoagulants… Read More
By Sandra Basu WASHINGTON – The maximum rates of annual pay for incoming VHA physicians and dentists would be increased as much as $35,000, under a VA proposal announced last month. The updated pay tables would allow physicians and dentists… Read More
VA Study Latest in Debate about Old Drug’s Safety By Brenda L. Mooney PALO ALTO, CA – A new study is calling into question the practice of treating atrial fibrillation with digoxin, finding that patients on the digitalis derivative were… Read More
By Annette M. Boyle MILWAUKEE – Many patients prefer the devil they know. When asked whether they want to go on or switch to a novel oral anticoagulant (NOAC) that requires little monitoring, has few drug-drug or food interactions, appears… Read More
By Annette M. Boyle ATLANTA – While three-quarters of stroke patients are older than 65, a “brain attack” can affect people of any age. For young American Indians and Alaskan Natives (AI/AN), that information is especially significant because they have… Read More
SILVER SPRING, MD — Military research is raising a new question about an old issue: Why do African-Americans have higher incidence rates of hypertension compared with servicemembers of other races and ethnicities despite equitable access to healthcare within the armed forces?
By Annette M. Boyle PALO ALTO, CA — Medication is only effective if taken, yet how to make sure patients maintain adherence with anticoagulants and many other long-term medications for chronic diseases poses one of the greatest dilemmas for healthcare… Read More
WASHINGTON — Use of novel anticoagulants has risen sharply both at the VA and in the Army in the last three years, freeing more atrial fibrillation patients from food restrictions and regular checks for coagulation time, as required when using warfarin.